Skip to main content
ROSSARI BIOTECH LIMITED logo

ROSSARI BIOTECH LIMITED — Investor Relations & Filings

Ticker · ROSSARI ISIN · INE02A801020 LEI · 335800R7XFRR8ZTHBQ25 BSE.NS Manufacturing
Open in API
Filings indexed 529 across all filing types
Latest filing 2022-05-19 Audit Report / Informat…
Country IN India
Listing BSE.NS ROSSARI

About ROSSARI BIOTECH LIMITED

https://www.rossari.com/

Rossari Biotech Limited is a specialty chemicals manufacturer focused on providing sustainable and innovative solutions across diverse sectors. The company operates through three primary business segments: Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals, and Animal Health and Nutrition. In the HPPC segment, it supplies essential ingredients for detergents, soaps, paints, and water treatment applications. Its textile division offers a comprehensive range of chemicals for the entire textile value chain, including pre-treatment, dyeing, and finishing processes. Additionally, the company provides high-quality feed additives and supplements for the poultry and livestock industries. Driven by robust research and development capabilities, Rossari Biotech emphasizes eco-friendly chemistry and customized formulations to meet specific client requirements. With advanced manufacturing facilities, the company serves a global clientele, maintaining a strong focus on operational excellence.

Recent filings

Filing Released Lang Actions
Dividend
Audit Report / Information Classification · 95% confidence The document is a detailed communication from Rossari Biotech Limited regarding the outcome of a Board Meeting held on May 19, 2022. It includes approval of audited financial results for the fiscal year ended March 31, 2022, along with the auditor's report containing an unmodified opinion. The document contains extensive auditor commentary on the audit process, management responsibilities, and audit conclusions, indicating it is the actual audit report rather than a mere announcement. The presence of detailed financial audit opinions and the full auditor's report text confirms this is a standalone audit report. It is not an Annual Report (10-K) because it does not contain the full company activity and financial performance report, but specifically focuses on the audit of financial results. It is not a short announcement or certification, so it is not RPA or RNS. Therefore, the document fits best under Audit Report / Information (AR).
2022-05-19 English
Outcome of Board Meeting
Regulatory Filings
2022-05-19 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Call Transcript Classification · 90% confidence The document is an announcement for a conference call scheduled on May 23, 2022, to discuss the Q4 & FY22 earnings results of Rossari Biotech Limited. It includes dial-in details, timing, and a brief description of the company. There are no actual financial statements or detailed financial analysis included in the text. The document is clearly a notice for an earnings conference call rather than the earnings release itself or a transcript of the call. Therefore, the appropriate classification is 'Call Transcript' (CT) as it relates to the earnings conference call event, even though the transcript itself is not included, this type best fits the nature of the document as a call announcement and preparation material for the call.
2022-05-18 English
Board Meeting — Dividend/Financial results
Regulatory Filings Classification · 95% confidence The document text contains only placeholders for omitted pictures and no substantive text content. The true document length is only 226 characters, which is extremely short and contains no financial data, report content, or announcements. It does not contain any report, announcement, or certification text. Given the lack of content and the presence of only images (which are omitted), this document cannot be classified as a report or announcement. It fits best as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings that do not fit elsewhere.
2022-05-11 English
General updates
Regulatory Filings Classification · 90% confidence The document text contains only placeholders for images and no textual content or substantive information. It is extremely short (175 characters) and does not contain any financial data, report titles, or regulatory references. Given the lack of content, it cannot be classified as a substantive report or announcement. It fits best as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings without clear classification.
2022-04-12 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document is titled 'Regulation 31(4)- Annual Declar' and contains a tabular list of entities/persons categorized as 'Promoter' or 'Promoter Group' for Rossari Biotech Limited with a financial year end of 31-Mar-2022. Regulation 31(4) typically relates to disclosures of shareholding or promoter holdings in Indian regulatory context. The document is a declaration or disclosure of shareholding by promoters and promoter groups rather than a financial report or management discussion. It is not an annual report, earnings release, or any detailed financial or management report. It is a regulatory disclosure of shareholding information. Given the nature and content, this fits best under Major Shareholding Notification (MRQ) which covers notifications of changes or declarations of significant share ownership levels. The document length is 3619 characters, relatively short and focused on shareholding disclosures, not a report publication announcement or regulatory filing of other types.
2022-04-05 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.